{"id":"https://genegraph.clinicalgenome.org/r/b880d39f-9579-42e4-a523-9df559b08f18v1.1","type":"EvidenceStrengthAssertion","dc:description":"HMOX1 was first reported in relation to autosomal recessive heme oxygenase deficiency in 1999 (Yachie et al., PMID: 9884342). The primary features of this condition include recurrent fever, hemolytic anemia, low serum bilirubin, elevated serum ferritin, and small or absent spleen. The underlying mechanism is a loss of heme oxidase activity leading to increased susceptibility to oxidative damage (PMID: 20055707).\n\nSix variants (nonsense, frameshift, splice site, whole exon deletion) that have been reported in five probands in five publications (PMIDs: 9884342; 210818618; 26526137; 32587840; 33066778) are included in this curation. Co-segregation with disease has not been observed. The mechanism of pathogenicity is biallelic loss of function. This gene-disease association is also supported by the known biological function of HMOX1, its expression pattern, functional alterations in patient and non-patient cells, and a non-human animal model (PMIDs: 9380735; 9380736; 9884342; 20055707; 25613900). \n\nIn summary, HMOX1 is definitively associated with autosomal recessive heme oxygenase deficiency 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time without the emergence of contradictory evidence. This classification was approved by the ClinGen General Inborn Errors of Metabolism GCEP on 12/18/2023 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b880d39f-9579-42e4-a523-9df559b08f18","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9f1a1080-6e62-4c89-9500-e5c74e078e06","calculatedEvidenceStrength":"Strong","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9f1a1080-6e62-4c89-9500-e5c74e078e06_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10097","date":"2023-12-20T16:58:59.353Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/9f1a1080-6e62-4c89-9500-e5c74e078e06_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10097","date":"2023-12-20T19:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f1a1080-6e62-4c89-9500-e5c74e078e06_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d453c00-2954-4f72-9e1c-4ea792bad03e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d453c00-2954-4f72-9e1c-4ea792bad03e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32587840","rdfs:label":"Taghighi 2019 - Patient 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":17,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b89438c8-0aad-494d-a69e-851ab089eeb2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002133.3(HMOX1):c.610A>T (p.Lys204Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411353387"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001954","obo:HP_0001878","obo:HP_0001894","obo:HP_0003281","obo:HP_0000093","obo:HP_0001746","obo:HP_0002240","obo:HP_0000790"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/469d1fd5-95c7-42ed-b9b4-7959730459f0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32587840","allele":{"id":"https://genegraph.clinicalgenome.org/r/b89438c8-0aad-494d-a69e-851ab089eeb2"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/469d1fd5-95c7-42ed-b9b4-7959730459f0","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/469d1fd5-95c7-42ed-b9b4-7959730459f0_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/b722dae4-ce54-4dad-ba0c-31b3c4eaf90e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b722dae4-ce54-4dad-ba0c-31b3c4eaf90e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21088618","rdfs:label":"Radhakrishnan 2011 - Patient 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d4f2b746-42b0-4532-afbf-dc277b1c75c3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002133.3(HMOX1):c.130C>T (p.Arg44Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10204619"}},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001746","obo:HP_0003281","obo:HP_0000093","obo:HP_0001954","obo:HP_0000790"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/34d84af2-d883-4615-8849-54fb73333b9f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21088618","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4f2b746-42b0-4532-afbf-dc277b1c75c3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/34d84af2-d883-4615-8849-54fb73333b9f","type":"EvidenceLine","dc:description":"Case score reduced for homozygosity","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34d84af2-d883-4615-8849-54fb73333b9f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/ae09ab23-2cbd-4f1b-88cc-4e5df3daf11a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae09ab23-2cbd-4f1b-88cc-4e5df3daf11a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26526137","rdfs:label":"Gupta 2016 - Patient 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d4f2b746-42b0-4532-afbf-dc277b1c75c3"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000093","obo:HP_0006270","obo:HP_0001878","obo:HP_0001894","obo:HP_0033480","obo:HP_0000790","obo:HP_0003281"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8df6a7fe-098e-4155-b05d-e9ce8e9b4459_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26526137","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4f2b746-42b0-4532-afbf-dc277b1c75c3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/8df6a7fe-098e-4155-b05d-e9ce8e9b4459","type":"EvidenceLine","dc:description":"Score reduced as a conservative measure against over-scoring a recurrent variant in a single genetic background","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8df6a7fe-098e-4155-b05d-e9ce8e9b4459_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/51b45924-6dfe-4575-9eb3-67644821fe17_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51b45924-6dfe-4575-9eb3-67644821fe17","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9884342","rdfs:label":"Yachie 1999 - Patient 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/98b18146-b302-44b6-8cdc-859d05c935f7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002133.3(HMOX1):c.324_325del (p.Pro109fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/15896"}},{"id":"https://genegraph.clinicalgenome.org/r/2ec881af-dc79-437d-ae0f-24c569187583","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000022.11:g.35383106_35383226del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580099707"}}],"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0003281","obo:HP_0002240","obo:HP_0033480","obo:HP_0001878","obo:HP_0000790","obo:HP_0001954","obo:HP_0001746","obo:HP_0000093"],"previousTesting":false,"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/4e17dacc-bb23-49b2-b707-69dae3471109_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9884342","allele":{"id":"https://genegraph.clinicalgenome.org/r/2ec881af-dc79-437d-ae0f-24c569187583"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/9b5afb7e-d659-4286-84d9-c3dd0c61890c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9884342","allele":{"id":"https://genegraph.clinicalgenome.org/r/98b18146-b302-44b6-8cdc-859d05c935f7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/4e17dacc-bb23-49b2-b707-69dae3471109","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e17dacc-bb23-49b2-b707-69dae3471109_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/4e17dacc-bb23-49b2-b707-69dae3471109_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Unscored;  IHC in patient liver biopsy revealed complete loss of HO-1 expression, while it was present in unaffected controls (Fig. 4)","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9b5afb7e-d659-4286-84d9-c3dd0c61890c","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b5afb7e-d659-4286-84d9-c3dd0c61890c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/9b5afb7e-d659-4286-84d9-c3dd0c61890c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Unscored;  IHC in patient liver biopsy revealed complete loss of HO-1 expression, while it was present in unaffected controls (Fig. 4)","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/892e50d8-139b-429f-a3c3-de0a9c8f8b36_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/892e50d8-139b-429f-a3c3-de0a9c8f8b36","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33066778","rdfs:label":"Chau 2020 - Patient 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":10,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/0493de27-35a7-4c22-a197-be7ec273435d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002133.3(HMOX1):c.262_268delinsCC (p.Ala88ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573055001"}},{"id":"https://genegraph.clinicalgenome.org/r/0320bdb5-97d3-44a8-9eae-55bc0fd052e3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002133.3(HMOX1):c.636+2T>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10204768"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001878","obo:HP_0003281","obo:HP_0001954","obo:HP_0001894","obo:HP_0030084","obo:HP_0001999","obo:HP_0002240","obo:HP_0000790","obo:HP_0000093","obo:HP_0001746"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0bf405d2-cf4e-4b12-95a7-9a7073c4448a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33066778","allele":{"id":"https://genegraph.clinicalgenome.org/r/0320bdb5-97d3-44a8-9eae-55bc0fd052e3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/f745f463-3bcb-4549-a8a8-44c11ef9b094_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33066778","allele":{"id":"https://genegraph.clinicalgenome.org/r/0493de27-35a7-4c22-a197-be7ec273435d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/f745f463-3bcb-4549-a8a8-44c11ef9b094","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f745f463-3bcb-4549-a8a8-44c11ef9b094_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0bf405d2-cf4e-4b12-95a7-9a7073c4448a","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bf405d2-cf4e-4b12-95a7-9a7073c4448a_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/9f1a1080-6e62-4c89-9500-e5c74e078e06_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f1a1080-6e62-4c89-9500-e5c74e078e06_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/539bfe41-fb7e-4213-abf3-f2b44e1037e9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c9c9097-6f1b-4570-a27a-7d3124b716de","type":"Finding","dc:description":"Protein Atlas uses a combination of transcriptomics and IHC to assess expression in multiple tissue types. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25613900","rdfs:label":"HMOX1 Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/05a0015e-47eb-4e5f-a027-5e1ebe246256","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3cf2bd0-d94d-4d87-a306-3ac706cf9ad4","type":"Finding","dc:description":"Heme oxygenase 1 (HO-1) breaks down free heme into biliverdin, carbon monoxide, and free iron. In addition to removing free heme as a source of oxidative damage, the products of this reaction contribute to direct antioxidant activity, either by inducing the transcription of cytoprotective genes or through the conversion of biliverdin to bilirubin. HO-1 deficient patients exhibit an increased susceptibility to oxidative damage and hemolytic anemia. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20055707","rdfs:label":"HMOX1 Function","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9f1a1080-6e62-4c89-9500-e5c74e078e06_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7a077b6-0b9d-446f-940d-e636d3f49c47","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9708290a-2688-4b24-b091-1559cda80720","type":"FunctionalAlteration","dc:description":"Northern blots were prepared using mRNA from wt mouse fibroblasts that had been treated with one of several oxidizing agents, demonstrating a dose-dependent induction of HMOX1 (Fig. 1). The authors then used flow cytometry to measure free radical-induced fluorescence in both wt and HMOX1 KO fibroblasts (Fig. 2). For each oxidizing agent, but particularly for hemin, fluorescence was significantly increased in these cells, demonstrating reduced antioxidant activity in mutant cells. Further, cell survival was affected (Fig. 3).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9380736","rdfs:label":"Cytotoxicity in KO cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f829aa27-7fc1-47cc-b92c-36c85942e2d4","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f51bc43d-9edc-4bef-9a23-33ec315f2be0","type":"FunctionalAlteration","dc:description":"Cultured lymphoblastoid cells from the patient and controls were treated with hemin, a known substrate of HO-1. Control cells were unaffected after 24hrs of treatment, while ~60% of patient cells were dead at the same time point. This effect was dose dependent, with higher levels leading to a stronger effect in control cells only (Fig. 6). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9884342","rdfs:label":"Increased cytotoxicity in patient cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9f1a1080-6e62-4c89-9500-e5c74e078e06_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/979f9c8a-164c-4706-bea5-6c55efe868c5","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b125ca95-f3b0-4154-bcc6-704682d30306","type":"Finding","dc:description":"These mice developed anemia and other hematological abnormalities consistent with human HMOX1 deficiency. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9380735","rdfs:label":"HMOX1 KO mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Strong","sequence":7263,"specifiedBy":"GeneValidityCriteria10","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/szWmJsa5m54","type":"GeneValidityProposition","disease":"obo:MONDO_0013536","gene":"hgnc:5013","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9f1a1080-6e62-4c89-9500-e5c74e078e06-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}